← Back to headlines
Eli Lilly Makes $2.8 Billion Investment Beyond GLP-1 Drugs
Eli Lilly has committed $2.8 billion to a new venture, signaling a strategic move to expand its portfolio beyond its highly successful GLP-1 drugs.
28 Jul, 16:35 — 28 Jul, 16:35
Sources
Showing 1 of 1 sources
